Skip to Content

Dexrazoxane use while Breastfeeding

Drugs containing Dexrazoxane: Totect, Zinecard

Medically reviewed by Drugs.com. Last updated on Aug 2, 2020.

Dexrazoxane Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of dexrazoxane during breastfeeding. The manufacturer recommends that women not breastfeed during treatment and for 2 weeks following the final dose of dexrazoxane. However, because dexrazoxane is used with doxorubicin, the abstinence period might be longer, depending on the doxorubicin dose.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Dexrazoxane

CAS Registry Number

24584-09-6

Drug Class

Breast Feeding

Lactation

Antineoplastic Agents

Cardioprotectants

Cardiotonic Agents

Enzyme Inhibitors

Topoisomerase II Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.